04-2: Role of Immunosuppression and TNF-Alpha Inhibition in Outcomes of Islet-alone and Islet-after-Kidney Transplantation: Report from The Collaborative Islet Transplant Registry
Go back to Resources
04-2: Role of Immunosuppression and TNF-Alpha Inhibition in Outcomes of Islet-alone and Islet-after-Kidney Transplantation: Report from The Collaborative Islet Transplant Registry
Authors:
Volume:
Pagination:
Issue:
Journal:
Keywords:
Abstract:
Intracoronary Cardiosphere-Derived Cells for Heart Regeneration After Myocardial Infarction (CADUCEUS): A Prospective, Randomised Phase 1 Trial
Go back to Resources
Intracoronary Cardiosphere-Derived Cells for Heart Regeneration After Myocardial Infarction (CADUCEUS): A Prospective, Randomised Phase 1 Trial
Authors:
Secondary:
Volume:
Pagination:
Abstract:
Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors
Go back to Resources
Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors
Authors:
Secondary:
Volume:
Pagination:
Keywords:
Abstract:
Myeloablative Transplantation Using Either Cord Blood or Bone Marrow Leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease
Go back to Resources
Myeloablative Transplantation Using Either Cord Blood or Bone Marrow Leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease
Authors:
Secondary:
Volume:
Pagination:
Keywords:
Abstract:
Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*
Go back to Resources
Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*
Authors:
Secondary:
Volume:
Pagination:
Keywords:
Abstract:
The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy
Go back to Resources
The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
Keywords:
Abstract:
Regulation of Cellular Therapy in the United States
Go back to Resources
Regulation of Cellular Therapy in the United States
Authors:
Secondary:
Pagination:
Publisher:
Editor(s):
Keywords:
Abstract:
Predictive Value of C-peptide Measures for Clinical Outcomes of Islet Transplantation in Type 1 Diabetes: a Report from the Collaborative Islet Transplant Registry (CITR)
Go back to Resources
Predictive Value of C-peptide Measures for Clinical Outcomes of Islet Transplantation in Type 1 Diabetes: a Report from the Collaborative Islet Transplant Registry (CITR)
Authors:
Secondary:
Location:
Go back to ResourcesLong-term Islet Transplant Outcomes: Keys to Long-term Success Future Challenges. Collaborative Islet Transplant Registry (CITR)
Go back to Resources
Long-term Islet Transplant Outcomes: Keys to Long-term Success Future Challenges. Collaborative Islet Transplant Registry (CITR)
Authors:
Secondary:
Location:
Go back to Resources